· Журналы · Книги · О проекте ·Электронные версии книг издательства “Атмосфера” поступили в продажу Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru ИНТЕРНЕТ-МАГАЗИН    Практическая пульмонология (ранее – "Атмосфера. Пульмонология и аллергология"): ISSN 2409-756X (Online), ISSN 2409-6636 (Print) 2021 / N 3 Цитокиновый шторм при COVID-19: аутопсийное наблюдение М.В. Самсонова, М.М. Белоцерковская, А.Л. Черняев, А.Г. Талалаев, Ж.Р. Омарова, Ю.С. Лебедин References 1. Lukan N. “Cytokine storm”, not only in COVID-19 patients. Mini-review. Immunology Letters 2020 Dec;228:38-44. 2. Lee DW, Gardner R, Porter DL, Louis CU, Ahmed N, Jensen M, Grupp SA, Mackall CL. Current concepts in the diagnosis and management of cytokine release syndrome. Blood 2014 Jul;124(2):188-95. 3. Fajgenbaum DC, June CH. Cytokine storm. The New England Journal of Medicine 2020 Dec;383(23):2255-73. 4. Potapnev MP. Cytokine storm: causes and consequences. Immunologiya 2021;42(2):175-89 (In Russian). 5. Chen LYC, Hoiland RL, Stukas S, Wellington CL, Sekhon MS. Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome. The European Respiratory Journal 2020 Oct;56(4):2003006. 6. Herold T, Jurinovic V, Arnreich C, Lipworth BJ, Hellmuth JC, von Bergwelt-Baildon M, Klein M, Weinberger T. Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. The Journal of Allergy and Clinical Immunology 2020 Jul;146(1):128-36.e4. 7. Ackermann M, Mentzer SJ, Kolb M, Jonigk D. Inflammation and intussusceptive angiogenesis in COVID-19: everything in and out of flow. The European Respiratory Journal 2020 Nov;56(5):2003147. 8. Liu Y, Tan W, Chen H, Zhu Y, Wan L, Jiang K, Guo Y, Tang K, Xie C, Yi H, Kuang Y, Luo Y. Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19. BMC Infectious Diseases 2021 Jan;21(1):79. 9. André S, Picard M, Cezar R, Roux-Dalvai F, Alleaume-Butaux A, Soundaramourty C, Cruz AS, Mendes-Frias A, Gotti C, Leclercq M, Nicolas A, Tauzin A, Carvalho A, Capela C, Pedrosa J, Castro AG, Kundura L, Loubet P, Sotto A, Muller L, Lefrant JY, Roger C, Claret PG, Duvnjak S, Tran TA, Racine G, Zghidi-Abouzid O, Nioche P, Silvestre R, Droit A, Mammano F, Corbeau P, Estaquier J. T cell apoptosis characterizes severe Covid-19 disease. Cell Death & Differentiation 2022 Jan 22:1-14. doi: 10.1038/s41418-022-00936-x. Epub ahead of print. 10. Ndebele K, Gona P, Jin TG, Benhaga N, Chalah A, Degli-Esposti M, Khosravi-Far R. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induced mitochondrial pathway to apoptosis and caspase activation is potentiated by phospholipid scramblase-3. Apoptosis 2008 Jul;13(7):845-56. 11. Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science (New York, N.Y.) 2020 May;368(6490):473-4. 12. RECOVERY Collaborative Group; Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ. Dexamethasone in hospitalized patients with Covid-19. The New England Journal of Medicine 2021 Feb;384(8):693-704. 13. Bratosin D, Estaquier J, Petit F, Arnoult D, Quatannens B, Tissier JP, Slomianny C, Sartiaux C, Alonso C, Huart JJ, Montreuil J, Ameisen JC. Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria. Cell Death & Differentiation 2001 Dec;8(12):1143-56. 14. Song P, Li W, Xie J, Hou Y, You C. Cytokine storm induced by SARS-CoV-2. Clinica Chimica Acta 2020 Oct;509:280-7. 15. Morris G, Bortolasci CC, Puri BK, Olive L, Marx W, O’Neil A, Athan E, Carvalho A, Maes M, Walder K, Berk M. Preventing the development of severe COVID-19 by modifying immunothrombosis. Life Sciences 2021 Jan;264:118617. 16. Bösmüller H, Matter M, Fend F, Tzankov A. The pulmonary pathology of COVID-19. Virchows Archiv 2021 Jan;478(1):137-50. 17. Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, Li WW, Li VW, Mentzer SJ, Jonigk D. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. The New England Journal of Medicine 2020 Jul;383(2):120-8. 18. Gu SX, Tyagi T, Jain K, Gu VW, Lee SH, Hwa JM, Kwan JM, Krause DS, Lee AI, Halene S, Martin KA, Chun HJ, Hwa J. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nature Reviews. Cardiology 2021 Mar;18(3):194-209. 19. Haslbauer JD, Stalder A, Zinner C, Bassetti S, Mertz KD, Went P, Matter M, Tzankov A. Immunohistochemical and transcriptional analysis of SARS-CoV-2 entry factors and renin-angiotensin-aldosterone system components in lethal COVID-19. Pathobiology 2021 Dec 16:1-12. doi: 10.1159/000520221. Online ahead of print. 20. Schurink B, Roos E, Radonic T, Barbe E, Bouman CSC, de Boer HH, de Bree GJ, Bulle EB, Aronica EM, Florquin S, Fronczek J, Heunks LMA, de Jong MD, Guo L, du Long R, Lutter R, Molenaar PCG, Neefjes-Borst EA, Niessen HWM, van Noesel CJM, Roelofs JJTH, Snijder EJ, Soer EC, Verheij J, Vlaar APJ, Vos W, van der Wel NN, van der Wal AC, van der Valk P, Bugiani M. Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study. The Lancet. Microbe 2020 Nov;1(7):e290-9. 21. Bradley BT, Maioli H, Johnston R, Chaudhry I, Fink SL, Xu H, Najafian B, Deutsch G, Lacy JM, Williams T, Yarid N, Marshall DA. Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series. The Lancet 2020 Aug;396(10247):320-332. 22. Bolevich CB, Bolevich SS. Complex mechanism of COVID-19 development. Sechenov Medical Journal 2020;11(2):50-61 (In Russian). 23. McGonagle D, O’Donnell JS, Sharif K, Emery P, Bridgewood C. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. The Lancet. Rheumatology 2020 Jul;2(7):e437-45. 24. Bryce C, Grimes Z, Pujadas E, Ahuja S, Beasley MB, Albrecht R, Hernandez T, Stock A, Zhao Z, Al Rasheed M, Chen J, Li L, Wang D, Corben A, Haines K, Westra W, Umphlett M, Gordon R, Reidy J, Petersen B, Salem F, Fiel M, Jamal S, Tsankova N, Houldsworth J, Mussa Z, Liu WC, Veremis B, Sordillo E, Gitman M, Nowak M, Brody R, Harpaz N, Merad M, Gnjatic S, Donnelly R, Seigler P, Keys C, Cameron J, Moultrie I, Washington K, Treatman J, Sebra R, Jhang J, Firpo A, Lednicky J, Paniz-Mondolfi A, Cordon-Cardo C, Fowkes M. Pathophysiology of SARS-CoV-2: targeting of endothelial cells renders a complex disease with thrombotic microangiopathy and aberrant immune response. The Mount Sinai COVID-19 autopsy experience. medRxiv 2020. Posted May 22, 2020. DOI: 10.1101/2020.05.18.20099960 25. Pershina ES, Chernyaev AL, Samsonova MV, Varyasin VV, Omarova ZhR, Pereshivaylov SO, Berezhnaya EE, Parshin VV, Mikhaylichenko KYu, Shilova AS, Shchekochikhin DYu, Gilyarov MYu. Comparison of the CT patterns and pulmonary histology in patients with COVID-19. Medical Visualization 2020;24(3):37-53 (In Russian).    [ Содержание выпуска N 3 | Выпуски журнала | Список журналов ]